{
    "id": 26990,
    "fullName": "ABL1 amp",
    "impact": "none",
    "proteinEffect": "no effect",
    "geneVariantDescriptions": [
        {
            "description": "ABL1 amplification indicates an increased number of copies of the ABL1 gene. However, the mechanism causing the increase is unspecified.",
            "references": [
                {
                    "id": 275,
                    "pubMedId": null,
                    "title": "External Reference Not Available (N/A)",
                    "url": "https://ckb.jax.org/about/glossaryOfTerms"
                }
            ]
        }
    ],
    "type": "non-specific",
    "gene": {
        "id": 25,
        "geneSymbol": "ABL1",
        "terms": [
            "ABL1",
            "ABL",
            "BCR-ABL",
            "bcr/abl",
            "c-ABL",
            "c-ABL1",
            "CHDSKM",
            "JTK7",
            "p150",
            "v-abl"
        ]
    },
    "variant": "amp",
    "createDate": "09/13/2017",
    "updateDate": "09/06/2018",
    "referenceTranscriptCoordinates": null,
    "partnerGenes": [
        
    ],
    "evidence": [
        {
            "id": 11923,
            "approvalStatus": "Case Reports/Case Series",
            "evidenceType": "Actionable",
            "efficacyEvidence": "In a clinical study, amplification of the BCR-ABL1 fusion was associated with acquired resistance to Gleevec (imatinib) in patients with chronic myeloid leukemia patients harboring BCR-ABL1 (PMID: 11423618).",
            "molecularProfile": {
                "id": 28357,
                "profileName": "BCR - ABL1 ABL1 amp BCR amp"
            },
            "therapy": {
                "id": 770,
                "therapyName": "Imatinib",
                "synonyms": null
            },
            "indication": {
                "id": 8552,
                "name": "chronic myeloid leukemia",
                "source": "DOID"
            },
            "responseType": "resistant",
            "references": [
                {
                    "id": 2379,
                    "pubMedId": 11423618,
                    "title": "Clinical resistance to STI-571 cancer therapy caused by BCR-ABL gene mutation or amplification.",
                    "url": "http://www.ncbi.nlm.nih.gov/pubmed/11423618"
                }
            ],
            "ampCapAscoEvidenceLevel": "D",
            "ampCapAscoInferredTier": "II"
        }
    ],
    "molecularProfiles": [
        {
            "id": 28357,
            "profileName": "BCR - ABL1 ABL1 amp BCR amp",
            "profileTreatmentApproaches": [
                
            ]
        },
        {
            "id": 28358,
            "profileName": "ABL1 amp",
            "profileTreatmentApproaches": [
                
            ]
        }
    ],
    "allTranscriptCoordinates": [
        
    ]
}